Results

Total Results: 2,505 records

Showing results for "diseases".

341. Draft Comparative Effectiveness Review Appendicies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
     April 01, 2005 - Imaging test: Laboratory test: Clinical exam test: Demographics: Concurrent diseases … Survival in renal vascular disease. … Surgery for renovascular diseases: a single-center experience in revascularizing renal artery stenosis … HTN and CKD • Populations had ≥60% to ≥80% stenosis • Populations had unilateral and bilateral diseases … that bilateral versus unilateral disease did not predict progressive kidney disease

342. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
     January 01, 2021 - psychological disorders; Vertebral fractures (Rx Control); Tumors (Rx Control); Diagnosed metabolic diseases … who were planning to become pregnant during the study period; (2) those who were suffering from other diseases … that increased the pain or another specific diagnosis, such as rheumatic, heart, and infectious diseases … NR NR NR Supported by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases … , major depression, comorbid diseases capable of affecting sympathetic skin response (SSR), history

343. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
     January 01, 2021 - psychological disorders; Vertebral fractures (Rx Control); Tumors (Rx Control); Diagnosed metabolic diseases … who were planning to become pregnant during the study period; (2) those who were suffering from other diseases … that increased the pain or another specific diagnosis, such as rheumatic, heart, and infectious diseases … NR NR NR Supported by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases … , major depression, comorbid diseases capable of affecting sympathetic skin response (SSR), history

344. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis_research-protocol.pdf
     June 06, 2011 - cause of mortality for women in the United States.1 Coronary heart disease—which includes coronary … Current diagnostic concepts to detect coronary artery disease in women. … Non-invasive imaging for coronary artery disease. Technology Assessment. … [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR … "coronary heart disease"[tiab]) + Comparisons: 6 groups of terms.

345. S158 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
     October 01, 2007 - Availability of information on disease outcome will affect choice of analytic strategies. … limitations when they are used to assess the role of medications in the etiology and management of chronic diseases … not have been completely controlled for in observational studies on pharmacopreven- tion of chronic diseases … These databases are, however, often the best source of information on the association between drugs and diseases … The treatment of unrelated disor- ders in patients with chronic medical diseases.

346. Automated-Entry Patient Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
     March 17, 2020 - assessed to determine efficacy related to health outcomes for consumers with (or at risk for) chronic diseases … obstructive pulmonary disease, or asthma. … Which specific chronic diseases do you think are most important for us to include? 3. … challenge to interpreting research and evaluation studies on consumer health technologies for chronic diseases … 'coronary artery disease'/exp OR (coronar*:ti AND arter*:ti AND (disease*:ti OR syndrome*:ti OR atheroscleros

347. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - , CHF with or without preserved LV function, diabetes, peripheral arterial disease, chronic kidney disease … disease, or chronic kidney disease) on ACEI/ARB/DRI effectiveness or harms in patients with hypertension … disease, prior coronary revascularization; single- vs. multi-vessel coronary artery disease) on ACE-I … , peripheral vascular disease, diabetes, chronic kidney disease, or congestive heart failure. … ICD-9 (International Classification of Diseases, Ninth Revision) and CPT (Current Procedural Terminology

348. Methods Guide for Medical Test Reviews Chapter 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
     July 01, 2012 - screening for reportable diseases such as syphilis or HIV. … Numerous clinical management effects might follow testing for coronary artery disease with CT. … An individual diagnosed with coronary disease might alter his or her lifestyle to reduce disease progression … Although the prognoses for some diseases are minimally modifiable with current treatments, most prognostic … Principles and practice of mass screening for disease. WHO Chronicle 1968;22:473. 8.

349. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
     January 01, 2011 - Beneficiaries, 2006-2008, by Age, Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease … Alaska Native 2006 6.9% 17.9% 5.0% Total All 2007 6.0% 13.2% 4.0% Age Disabled/end stage renal disease … Alaska Native 2007 6.8% 17.5% 4.9% Total All 2008 6.0% 13.1% 3.9% Age Disabled/end stage renal disease … With Diabetes and Without PAD Total All 2006 0.5% 2.1% 0.053% Age Disabled/end stage renal disease … 2.08% 2.07% 1.93% 1.55% Total All 2008 1.70% 1.78% 1.70% 1.43% Age† Disabled/end stage renal disease

350. Treatment of Dementia Among Community-Dwelling and Institutionalized Medicare Beneficiaries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
     May 01, 2008 - Lewy bodies, and mixed forms of dementia. 1 ADRD are prevalent, devastating, and costly diseases affecting … Alzheimer’s disease was defined using the 331 code. … Rates of use were highest among those with a claim for Alzheimer’s Disease. … Alzheimer disease in the US population: Prevalence estimates using the 2000 census. … The accuracy of medicare claims data in identifying Alzheimer's disease.

351. Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
     August 01, 2024 - doublet chemoradiation (CRT) with 5-fluorouracil (5FU) plus mitomycin (MMC) likely results in greater disease-free … • Compared with concurrent CRT with 5FU, CRT with 5FU plus MMC may result in greater disease-free … with capecitabine plus MMC, CRT with paclitaxel plus capecitabine plus MMC showed greater overall, disease … Moderate Disease-specific mortality (up to 5 yrs) 1; RCT; n=585 CRT favored over RT alone; rate … Low Disease-free survival (up to 3 yrs) 1; RCT; n=144 Significantly greater in the paclitaxel arm

352. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - in this field focuses on drugs and biologics for irritable bowel syndrome and inflammatory bowel diseases … Bethesda (MD): National Digestive Diseases Information Clearinghouse (NDDIC); 2007 May [updated … National Digestive Diseases Information Clearinghouse (NDDIC). Short bowel syndrome. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National … Teduglutide, a glucagon-like peptide- 2 analog for the treatment of gastrointestinal diseases, including

353. Methods Guide for Medical Test Reviews Chapter 6 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
     July 01, 2012 - Spectrum of disease in practice and in studies. Source of population not described. … Exclude if no disease outcomes and outcomes key to understanding intended use case. … Spectrum Effect The severity or type of disease may effect the accuracy of the test. … or fetal anatomic survey, and MRI for detection of spinal conditions or joint disease. … Prevalence is inexorably tied to disease definitions that may also change over time.

354. Fecal-Incontinence Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
     November 30, 2014 - or muscle atrophy), due to an underlying gastrointestinal (GI) disorder (e.g., inflammatory bowel disease … Alterations in gastrointestinal (GI) motility or fecal texture (due to conditions or ingestibles) • Crohn’s disease … Available at: http://www.mayoclinic.org/diseases- conditions/fecal- incontinence/basics/definition/con … http://www.mayoclinic.org/diseases-conditions/fecal-incontinence/basics/definition/con-20034575 http … Management of faecal incontinence and constipation in adults with central neurological diseases.

355. Searching for Relevant Studies (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
     January 01, 2011 - Searches would include the disease, intervention, and terms for RCTs. … However, it is also sufficient to include the intervention, harms, and the disease of interest. … Arterial occlusive disease/ Peripheral vascular diseases/ Vascular diseases/ Atherosclerosis/ Cardiovascular … diseases/ Carotid artery diseases/ (((preserved adj left) or (stable adj cad) or (stable adj chd) or … adj lvef) or (normal adj ef)).mp 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 Terms for vascular diseases

356. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
     September 27, 2012 - Hepatic metastasis from colorectal cancer is defined as resectable when it is anticipated that disease … The volume of disease in these patients is small, either in terms of lesion size or number of lesions … Patients whose treatment has failed or whose disease progressed while receiving systemic chemotherapy … These patients generally have large–volume, diffuse disease and are not candidates for ablation but … Intermediate outcomes that impact overall survival include time to progression of disease and tumor

357. Liver-Cancer-Therapy Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
     May 01, 2013 - to differentiate between patients with BCLC stage A and B liver disease across publications. … This was calculated from the date of disease response to treatment to the date of disease progression … Subgroups of interest include age, sex, HCC stage, disease etiology, lesion size, and multifocal disease … • No studies presented subgroup analyses on age, sex, disease etiology, or HCC stage. … RFA to PEI/PAI: disease etiology Insufficient None of the 3 RCTs reported subgroup analysis by disease

358. renal-update-2015-150115 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-update_research-protocol.pdf
     January 15, 2015 - and ischemic kidney disease. … among the elderly and those with diffuse atherosclerotic vascular diseases. … FDA-Approved Medical Devices for Cardiology and Vascular Diseases. 2012; http://www.fda.gov/ForConsumers … American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation. … ((chronic kidney disease or CKD) and (stage IV or stage V)).af. 23.

359. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology, Annals of Rheumatic Diseases … oral   DMARD:  Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE BMJ JAMA LANCET NEW ENGLAND JOURNAL OF MEDICINE ANNALS OF THE RHEUMATIC DISEASES

360. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
     March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology, Annals of Rheumatic Diseases … oral   DMARD:  Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE BMJ JAMA LANCET NEW ENGLAND JOURNAL OF MEDICINE ANNALS OF THE RHEUMATIC DISEASES